The expression of KAT13B has been shown to be overexpressed in 27% of non-small cell lung cancer (NSCLC) patients correlating with poor disease-free (P = 0.0015) and overall (P = 0.0008) survival (Table 2, Figure 1) [88]. The gene discussed is NCOA3; the disease is non-small cell lung carcinoma.